EDP Sciences logo
Subscriber Authentication Point
Search
Menu
Home All issues Volume 29 / No 10 (Octobre 2013) Med Sci (Paris), 29 10 (2013) 897-905 References
Free Access
Issue
Med Sci (Paris)
Volume 29, Number 10, Octobre 2013
Page(s) 897 - 905
Section M/S Revues
DOI https://doi.org/10.1051/medsci/20132910018
Published online 18 October 2013
  1. Peterson JR, Mitchison TJ. Small molecules, big impact : a history of chemical inhibitors and the cytoskeleton. Chem Biol 2002 ; 9 : 1275–1285. [CrossRef] [PubMed] [Google Scholar]
  2. Eggert US. The why and how of phenotypic small-molecule screens. Nat Chem Biol 2013 ; 9 : 206–209. [CrossRef] [PubMed] [Google Scholar]
  3. Mayer TU, Kapoor TM, Haggarty SJ, et al. Small molecule inhibitor of mitotic spindle bipolarity identified in a phenotype-based screen. Science 1999 ; 286 : 971–974. [CrossRef] [PubMed] [Google Scholar]
  4. Lefurgy S, Cornish V. Finding Cinderella after the ball : a three-hybrid approach to drug target identification. Chem Biol 2004 ; 11 : 151–153. [PubMed] [Google Scholar]
  5. Prudent R, Vassal-Stermann E, Nguyen CH, et al. Pharmacological inhibition of LIM kinase stabilizes microtubules and inhibits neoplastic growth. Cancer Res 2012 ; 72 : 4429–4439. [CrossRef] [PubMed] [Google Scholar]
  6. Swinney DC, Anthony J. How were new medicines discovered? Nat Rev Drug Discov 2011 ; 10 : 507–519. [CrossRef] [PubMed] [Google Scholar]
  7. Miller OJ, El Harrak A, Mangeat T, et al. High-resolution dose-response screening using droplet-based microfluidics. Proc Natl Acad Sci USA 2012 ; 109 : 378–383. [Google Scholar]
  8. Malo N, Hanley JA, Cerquozzi S, et al. Statistical practice in high-throughput screening data analysis. Nat Biotechnol 2006 ; 24 : 167–175. [CrossRef] [PubMed] [Google Scholar]
  9. Soleilhac E, Nadon R, Lafanechere L. High-content screening for the discovery of pharmacological compounds : advantages, challenges and potential benefits of recent technological developments. Expert Opin Drug Discov 2010 ; 5 : 135–144. [CrossRef] [PubMed] [Google Scholar]
  10. Lo E, Soleilhac E, Martinez A, et al. Intensity quantile estimation and mapping-a novel algorithm for the correction of image non-uniformity bias in HCS data. Bioinformatics 2012 ; 28 : 2632–2639. [Google Scholar]
  11. Raj L, Ide T, Gurkar AU, et al. Selective killing of cancer cells by a small molecule targeting the stress response to ROS. Nature 2011 ; 475 : 231–234. [CrossRef] [PubMed] [Google Scholar]
  12. Vassal E, Barette C, Fonrose X, et al. Miniaturization and validation of a sensitive multiparametric cell-based assay for the concomitant detection of microtubule-destabilizing and microtubule-stabilizing agents. J Biomol Screen 2006 ; 11 : 377–389. [CrossRef] [PubMed] [Google Scholar]
  13. Prudent R, Vassal-Stermann E, Nguyen CH, et al. Azaindole derivatives are inhibitors of microtubule dynamics, with anti-cancer and anti-angiogenic activities. Br J Pharmacol 2013 ; 168 : 673–685. [CrossRef] [PubMed] [Google Scholar]
  14. Morelli X, Bourgeas R, Roche P. Chemical and structural lessons from recent successes in protein-protein interaction inhibition (2P2I). Curr Opin Chem Biol 2011 ; 15 : 475–481. [CrossRef] [PubMed] [Google Scholar]
  15. Harvey AL. Natural products as a screening resource. Curr Opin Chem Biol 2007 ; 11 : 480–484. [CrossRef] [PubMed] [Google Scholar]
  16. Fonrose X, Ausseil F, Soleilhac E, et al. Parthenolide inhibits tubulin carboxypeptidase activity. Cancer Res 2007 ; 67 : 3371–3378. [CrossRef] [PubMed] [Google Scholar]
  17. Loison S, Cottet M, Orcel H, et al. Selective fluorescent nonpeptidic antagonists for vasopressin V₂ GPCR : application to ligand screening and oligomerization assays. J Med Chem 2012 ; 55 : 8588–8602. [CrossRef] [PubMed] [Google Scholar]
  18. Laudet B, Prudent R, Filhol O, Cochet C. Des agents thérapeutiques ciblant des interactions protéine-protéine. Med Sci (Paris) 2007 ; 23 : 273–278. [Google Scholar]
  19. Guiffant D, Tribouillard D, Gug F, et al. Identification of intracellular targets of small molecular weight chemical compounds using affinity chromatography. Biotechnol J 2007 ; 2 : 68–75. [CrossRef] [PubMed] [Google Scholar]
  20. Titov D V, Liu JO. Identification and validation of protein targets of bioactive small molecules. Bioorg Med Chem 2012 ; 20 : 1902–1909. [CrossRef] [PubMed] [Google Scholar]
  21. Lomenick B, Hao R, Jonai N, et al. Target identification using drug affinity responsive target stability (DARTS). Proc Natl Acad Sci USA 2009 ; 106 : 21984–21989. [CrossRef] [Google Scholar]
  22. Terstappen GC, Schlüpen C, Raggiaschi R, Gaviraghi G. Target deconvolution strategies in drug discovery. Nat Rev Drug Discov 2007 ; 6 : 891–903. [CrossRef] [PubMed] [Google Scholar]
  23. Peterson JR, Lebensohn AM, Pelish HE, Kirschner MW. Biochemical suppression of small-molecule inhibitors : a strategy to identify inhibitor targets and signaling pathway components. Chem Biol 2006 ; 13 : 443–452. [CrossRef] [PubMed] [Google Scholar]
  24. Lehár J, Zimmermann GR, Krueger AS, et al. Chemical combination effects predict connectivity in biological systems. Mol Syst Biol 2007 ; 3 : 80. [CrossRef] [PubMed] [Google Scholar]
  25. Neumann B, Walter T, Hériché JK, et al. Phenotypic profiling of the human genome by time-lapse microscopy reveals cell division genes. Nature 2010 ; 464 : 721–727. [CrossRef] [PubMed] [Google Scholar]
  26. Baetz K, McHardy L, Gable K, et al. Yeast genome-wide drug-induced haploinsufficiency screen to determine drug mode of action. Proc Natl Acad Sci USA 2004 ; 101 : 4525–4530. [CrossRef] [Google Scholar]
  27. Ferlini C, Cicchillitti L, Raspaglio G, et al. Paclitaxel directly binds to Bcl-2 and functionally mimics activity of Nur77. Cancer Res 2009 ; 69 : 6906–6914. [CrossRef] [PubMed] [Google Scholar]
  28. Stechmann B, Bai SK, Gobbo E, et al. Inhibition of retrograde transport protects mice from lethal ricin challenge. Cell 2010 ; 141 : 231–242. [CrossRef] [PubMed] [Google Scholar]
  29. Botté CY, Deligny M, Roccia A, et al. Chemical inhibitors of monogalactosyldiacylglycerol synthases in Arabidopsis thaliana. Nat Chem Biol 2011 ; 7 : 834–842. [CrossRef] [PubMed] [Google Scholar]
  30. Willand N, Dirié B, Carette X, et al. Synthetic EthR inhibitors boost antituberculous activity of ethionamide. Nat Med 2009 ; 15 : 537–544. [CrossRef] [PubMed] [Google Scholar]
  31. Maurel D, Comps-Agrar L, Brock C, et al. Cell-surface protein-protein interaction analysis with time-resolved FRET and snap-tag technologies : application to GPCR oligomerization. Nat Methods 2008 ; 5 : 561–567. [CrossRef] [PubMed] [Google Scholar]
  32. Pauwels E, Surdez D, Stoll G, et al. A probabilistic model for cell population phenotyping using HCS data. PloS One 2012 ; 7 : e42715. [CrossRef] [PubMed] [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.